Skip to main content
. 2011 Sep-Oct;16(5):311–316. doi: 10.1155/2011/807123

TABLE 8.

Number of women with normal or decreased sexual desire and abnormal hormones who were treated with opioid or nonopioid analgesics

Decreased sexual desire
Normal sexual desire
Hormones Nonmenopausal
χ2 P Hormones Nonmenopausal
χ2 P
Control Opioid Control Opioid

Low FT 0/6 2/18 0.73 0.39 Low FT 0/3 2/11 0.64 0.43
Low TT 0/5 8/16 4.04 0.04 Low TT 0/3 3/11 1.04 0.31
High prolactin 0/7 1/19 0.38 0.54 High prolactin 1/3 2/11 0.32 0.57
Low DHEAS 1/7 7/19 1.22 0.27 Low DHEAS 0/3 2/11 0.64 0.43
High SHBG 0/4 2/14 0.64 0.42 High SHBG 0/3 0/6
Low T/SHBG 0/2 7/12 2.33 0.13 Low T/SHBG 0/3 2/6 1.29 0.26

Decreased sexual desire
Normal sexual desire
Hormones Menopausal
χ2 P Hormones Menopausal
χ2 P
Control Opioid Control Opioid

Low FT 0/6 2/13 1.03 0.31 Low FT 0/2 0/3
Low TT 3/6 4/13 0.65 0.42 low TT 0/2 1/3 0.83 0.36
High prolactin 0/6 1/13 0.49 0.49 High prolactin 1/2 0/3 1.88 0.17
Low DHEAS 0/6 5/13 3.13 0.08 High DHEAS 1/2 1/3 0.14 0.71
High SHBG 1/2 1/12 2.43 0.12 High SHBG 0/1 0/3
Low T/SHBG 0/2 3/12 0.64 0.43 Low T/SHBG 0/1 0/3

Data presented as n/N. DHEAS Dehydroepiandrosterone sulphate; FT Free testosterone; SHBG Sex hormone-binding globulin; T Testosterone; TT Total testosterone

HHS Vulnerability Disclosure